“Novel MAAP Variants Enhance Adeno-Associated Virus Production for Gene Therapy”

https://pubmed.ncbi.nlm.nih.gov/38115579

Scientists have evolved novel membrane-associated accessory protein (MAAP) variants that increase adeno-associated virus (AAV) production, potentially addressing a major hurdle in the gene therapy industry.